• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Protein FAN (NSMAF), Truncated

ACP12682

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP12682 Target NameNSMAF
Target SynonymsNSMAF; FANProtein FAN; Factor associated with neutral sphingomyelinase activation; Factor associated with N-SMase activationFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ92636
Background Information
  • Uniprot Id

    Q92636

  • Target Species

    Human

  • Target Name

    NSMAF

  • Target Full Name

    Protein FAN

  • Target Function

    Couples the p55 TNF-receptor (TNF-R55 / TNFR1) to neutral sphingomyelinase (N-SMASE). Specifically binds to the N-smase activation domain of TNF-R55. May regulate ceramide production by N-SMASE.

  • Target Tissue Specificity

    Ubiquitous.

  • Target Synonyms

    NSMAF; FANProtein FAN; Factor associated with neutral sphingomyelinase activation; Factor associated with N-SMase activation

  • Target Background

    This gene encodes a WD-repeat protein that binds the cytoplasmic sphingomyelinase activation domain of the 55kD tumor necrosis factor receptor. This protein is required for TNF-mediated activation of neutral sphingomyelinase and may play a role in regulating TNF-induced cellular responses such as inflammation. Alternative splicing results in multiple transcript variants.

Inquire Recombinant Human Protein FAN (NSMAF), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification